Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

MYD88 L265P Somatic Mutation

16 Aug 2013

Abstract excerpt

OBJECTIVES: To examine the usefulness of the MYD88 L265P somatic mutation in identifying cases of lymphoplasmacytic lymphoma (LPL) from other lymphoplasmacytic neoplasms in bone marrow biopsy specimens. METHODS: We studied 64 bone marrow biopsy specimens with involvement by various small B-cell lymphomas or plasma cell myeloma. RESULTS: The MYD88 L265P somatic mutation was present in 13/13 cases of LPL, 1/13...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Hematological disorders and diagnostics
Share to Lymphoma Diagnosis and Treatment
Share to Multiple Myeloma Research and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 23955458
DOI: 10.1309/ajcp10zclfzgyzip

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

MYD88 L265P Somatic MutationPMID 23955458Read ↗

MYD88 L265P mutation analysis helps define nodal lymphoplasmacytic lymphoma.Semantic proximity Read ↗

Defining Lymphoplasmacytic Lymphoma: Does MYD88L265P Define a Pathologically Distinct Entity Among Patients With an IgM Paraprotein and Bone Marrow-Based Low-Grade B-Cell Lymphomas With Plasmacytic Differentiation?Semantic proximity Read ↗

Lymphoplasmacytic Lymphoma With a Non-IgM Paraprotein Shows Clinical and Pathologic Heterogeneity and May Harbor MYD88 L265P Mutations.Semantic proximity Read ↗

MYD88 (L265P) somatic mutation in marginal zone B-cell lymphoma.Semantic proximity Read ↗

A Somatic Variant in MYD88 (L265P) Revealed by Whole Genome Sequencing Differentiates Lymphoplasmacytic Lymphoma From Marginal Zone LymphomasSemantic proximity Read ↗

Detection of MYD88 L265P mutations in formalin-fixed and decalcified BM biopsies from patients with lymphoplasmacytic lymphoma.Semantic proximity Read ↗

Preneoplastic somatic mutations including MYD88L265P in lymphoplasmacytic lymphoma.Semantic proximity Read ↗

Significance of MYD88 L265P Mutation Status in the Subclassification of Low-Grade B-Cell Lymphoma/Leukemia.Semantic proximity Read ↗

Role of MYD88 in lymphoplasmacytic lymphoma diagnosis and pathogenesis.Semantic proximity Read ↗

Aggressive Lymphoplasmacytic Neoplasm With an Unusual In-frame Deletion of MYD88 Associated With TRAF3 and TP53 Mutations and Complex Karyotype.Semantic proximity Read ↗

Clinicopathologic significance of MYD88 L265P mutation in diffuse large B-cell lymphoma: a meta-analysis.Semantic proximity Read ↗

Clone-specific MYD88 L265P and CXCR4 mutation status can provide clinical utility in suspected Waldenström macroglobulinemia/lymphoplasmacytic lymphoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.